Background We have previously estimated that respiratory syncytial virus (RSV) was associated
with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in …

Asthma is responsible for considerable global morbidity and health-care costs. Substantial
progress was made against key outcomes such as hospital admissions with asthma and …

Respiratory syncytial virus is the second most common cause of infant mortality and a major
cause of morbidity and mortality in older adults (aged >60 years). Efforts to develop a …

Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …

Background Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract
infection and hospitalization in infants. Nirsevimab is a monoclonal antibody to the RSV fusion …

Background For microbiological confirmation of diagnosis of pulmonary tuberculosis in young
children, sequential gastric lavages are recommended; sputum induction has not been …

Background Respiratory syncytial virus (RSV) is the most common cause of acute lower
respiratory infection in young children. We previously estimated that in 2015, 33·1 million …

Respiratory epithelial cells play a crucial role in the inflammatory response during
Pseudomonas aeruginosa infection in the lungs of patients with cystic fibrosis. In this study, we …

Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …

Background WHO recommends that Xpert MTB/RIF replaces smear microscopy for initial
diagnosis of suspected HIV-associated tuberculosis or multidrug-resistant pulmonary …